Galenica : expands its digital offering in the B2B segment



	PRESS RELEASE
Date	12 July 2022
Contact	Investor Relations: Julian Fiessinger, Head of Investor Relations & Corporate Finance
	Media Relations: Andreas Petrosino, Business Partner Corporate Communications
Subject	Galenica acquires Aquantic Ltd.

Galenica expands its digital offering in the B2B segment

Galenica is acquiring 100% of the shares in Aquantic Ltd. The acquisition will give Galenica access to a digital ecosystem that, by linking pharmaceutical companies and health insurance providers, will significantly simplify the assumption of the costs of specific medicines. In doing so, Galenica is expanding its digital offering for business customers (B2B) and increasing both efficiency in healthcare and quality for its partners and for patients.

Aquantic specialises in software solutions related to Article 71 a-d of the Health Insurance Ordinance (HIO). This article allows medicinal products or indications of medicinal products to be reimbursed in exceptional cases even if they are not on the federal list of specialities. This regulation is relevant, for example, in cases of rare, very severe or chronic disease and high therapeutic usefulness. The SmartMIP software solution by Aquantic enables this remuneration to be processed quickly, in a standardized manner and in compliance with the law within the meaning of Article 71 a-d HIO.

With the addition of Aquantic's services, Galenica is taking a step forward in the digitalisation of healthcare also in the B2B sector and is connecting health insurers and pharmaceutical companies. In this way, Galenica helps to shape a growing ecosystem in which the players work together. SmartMIP is already in use at 23 health insurance providers and 19 pharmaceutical companies.

In future, Aquantic will be managed as an independent Business Unit within the Galenica Group and will support the specialty pharmacy Mediservice. Aquantic's solution and extensive experience will enable Mediservice to expand its Article 71 expertise and optimise its services. Aquantic will benefit from its affiliation with the Galenica Group by gaining even wider market access and will help to consolidate Mediservice's market-leading position.

Daniele Madonna, Head of Healthcare at Galenica, says: "We warmly welcome the Aquantic team to the Galenica Group. The cooperation once again shows how important digital solutions are for us, including in the B2B sector. We are very pleased to be able to strengthen our expertise in Article 71 and thus offer partner companies and ultimately our customers an even better service and even greater quality."

Chris Wenger, Managing Director of Aquantic, adds: "Galenica is the perfect environment for us to further develop our innovative solutions and connect market players so that we can meet the digital challenges of the healthcare sector together with an effective platform."

The parties have agreed not to disclose the purchase price of the shares.

Galenica Ltd.

P.O. Box · Untermattweg 8 · CH-3001 Bern Phone [phone] · Fax [phone] [e-mail] · www.galenica.com

Galenica - Health and well-being are at the heart of what we do.

Date	12 July 2022
Page	2/2
Subject	Galenica acquires Aquantic Ltd.

For further information, please contact:
Media Relations:	Investor Relations:
Andreas Petrosino	Julian Fiessinger
Business Partner Corporate Communications	Head of Investor Relations
Tel. [phone]	Tel. [phone]
E-mail:[e-mail]	E-mail:[e-mail]

About Galenica

Galenica is the leading fully integrated healthcare provider in Switzerland. With over 500 own, joint venture and independent partner pharmacies, Galenica operates the largest network of pharmacies in Switzerland. In addition, Galenica develops and offers well-known own brands and products and exclusive brands and products from business partners, as well as offering a variety of on-site health services and tests for customers. Galenica is also the leading provider of both pre-wholesale and wholesale distribution services and database services in the Swiss healthcare market. Galenica is listed on the Swiss Stock Exchange (SIX Swiss Exchange, GALE, security number 36,067,446).

Additional information concerning Galenica can be found at www.galenica.com.

About Aquantic

Aquantic Ltd. is a Swiss software development and consulting firm and is considered a leading specialist in Art. 71a-d of the Health Insurance Ordinance (HIO) and pricing models.

Aquantic has been active in the healthcare sector for over 20 years and is therefore very familiar with the sector's requirements and challenges. The company's aim is to help its customers stay one step ahead by using its software solution, as reflected in its slogan: "CLEARLY AHEAD".

Since 2015, Aquantic has engaged intensively with Article 71a-d HIO and specialities list pricing models, resulting in the SmartWorld product range. Aquantic thus covers the entire process from the service provider to the pharmaceutical company.